Alessandro BartoloniMaria Elena RemoliFrancesca FarchiLorenzo ZammarchiClaudia FortunaEleonora BenedettiMaria Grazia CiufoliniFabio MacchioniPatricia RojasYunni Lara2026-03-222026-03-22201810.1002/jmv.25283https://doi.org/10.1002/jmv.25283https://andeanlibrary.org/handle/123456789/51072Citaciones: 4To determine the seroprevalence of antibodies against dengue virus (DENV) and West Nile virus (WNV) in the human population of the Bolivian Chaco, we tested 256 inhabitants of two rural communities. The seroprevalence, confirmed by plaque reduction neutralization test, was 7.8% and 2.7% for DENV and WNV, respectively.enSeroprevalenceVirologyDengue feverPlaque reduction neutralization testDengue virusFlavivirusPopulationWest Nile virusVirusBiologyarticle